Loader
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
Cancerversaries can be meaningful days of celebration for cancer survivors. Senior social work counselor Tabeen Urbach shares ways to mark a cancerversary and why it’s…
Advanced practice providers can lead clinical teams and patients to boost oncology clinical trial enrollment, a nurse practitioner explained.
Premal Thaker, MD, MS, discusses how the RAMP-201 trial paved a way for the RAMP-301 trial of avutometinib/defactinib in low-grade serous ovarian cancer.
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Charles Simone, MD, argued that surgical approaches have a limited…
In case you missed any, below is a recap of every episode of OncLive On Air that aired in March 2024.
Pediatric MLLT10+ AML have poor prognosis and may benefit from targeted therapies.Patients with PICALM::MLLT10+ and X::MLLT10+ exhibit DNA hypermethylation
Can AI-enabled technology safeguard hospitals, pharmacies, and medical devices from cyberattacks? To access this subscriber-only content please log in or renew your subscription.Looking for IP…
HHV-6B reactivation affects approximately half of all allogeneic hematopoietic cell transplant (HCT) recipients. HHV-6B is the most frequent infectious cause of encephalitis following HCT and…
Background: B-cell acute lymphoblastic leukemia (B-ALL) is the most common childhood malignancy. Medullary and extramedullary disease relapse is a well-known occurrence in B-ALL pediatric patients…
Kara N. Maxwell, MD, PhD, discusses strategies to optimize the utility of genetic testing to better inform decision-making in prostate cancer treatment.